Blueshift Asset Management, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Blueshift Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$26.46 - $37.15 $444,475 - $624,045	-16,798 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$32.73 - $47.95 $369,488 - $541,307	11,289 Added 204.92%	16,798 $615,000
Q1 2021 May 06, 2021	SELL	$40.39 - $56.73 $88,979 - $124,976	-2,203 Reduced 28.57%	5,509 $247,000
Q4 2020 Feb 12, 2021	BUY	$51.77 - $66.18 $399,250 - $510,380	7,712 New	7,712 $440,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.